Jeremy P. Feldman

434 total citations
26 papers, 272 citations indexed

About

Jeremy P. Feldman is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Jeremy P. Feldman has authored 26 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 9 papers in Cardiology and Cardiovascular Medicine and 6 papers in Genetics. Recurrent topics in Jeremy P. Feldman's work include Pulmonary Hypertension Research and Treatments (17 papers), Vascular Anomalies and Treatments (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Jeremy P. Feldman is often cited by papers focused on Pulmonary Hypertension Research and Treatments (17 papers), Vascular Anomalies and Treatments (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Jeremy P. Feldman collaborates with scholars based in United States, France and Germany. Jeremy P. Feldman's co-authors include Mitchell S. Buckley, Murali M. Chakinala, R. James White, Michael A. Mathier, Franz Rischard, Kevin Laliberte, Meredith Broderick, Shelley Shapiro, Mardi Gomberg‐Maitland and Aaron B. Waxman and has published in prestigious journals such as CHEST Journal, The Journal of Heart and Lung Transplantation and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Jeremy P. Feldman

25 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeremy P. Feldman United States 9 235 165 39 26 17 26 272
Elizabeth Pielsticker United States 6 239 1.0× 165 1.0× 51 1.3× 43 1.7× 26 1.5× 11 288
Ségolène Turquier France 7 179 0.8× 92 0.6× 16 0.4× 19 0.7× 16 0.9× 17 194
Efrén Santos Mexico 5 323 1.4× 281 1.7× 29 0.7× 42 1.6× 97 5.7× 9 356
Athiththan Yogeswaran Germany 12 246 1.0× 219 1.3× 16 0.4× 39 1.5× 54 3.2× 37 310
Maurizio Pin Italy 9 186 0.8× 164 1.0× 42 1.1× 27 1.0× 24 1.4× 22 221
Emir Karaçağlar Türkiye 7 82 0.3× 105 0.6× 8 0.2× 40 1.5× 17 1.0× 33 170
Katarzyna Małaczyńska-Rajpold United Kingdom 9 92 0.4× 148 0.9× 7 0.2× 30 1.2× 13 0.8× 26 217
Janette T. Reyes Canada 7 345 1.5× 247 1.5× 61 1.6× 62 2.4× 148 8.7× 9 395
Rachel Crackett United Kingdom 2 264 1.1× 212 1.3× 102 2.6× 15 0.6× 16 0.9× 5 286
Willemijn M. H. Zijlstra Netherlands 7 313 1.3× 220 1.3× 63 1.6× 39 1.5× 144 8.5× 10 323

Countries citing papers authored by Jeremy P. Feldman

Since Specialization
Citations

This map shows the geographic impact of Jeremy P. Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy P. Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy P. Feldman more than expected).

Fields of papers citing papers by Jeremy P. Feldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy P. Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy P. Feldman. The network helps show where Jeremy P. Feldman may publish in the future.

Co-authorship network of co-authors of Jeremy P. Feldman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy P. Feldman. A scholar is included among the top collaborators of Jeremy P. Feldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy P. Feldman. Jeremy P. Feldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gillies, Hunter, Murali M. Chakinala, Benjamin T. Dake, et al.. (2024). IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension. Pulmonary Circulation. 14(1). e12352–e12352. 5 indexed citations
2.
Montani, David, Vallerie V. McLaughlin, Mardi Gomberg‐Maitland, et al.. (2024). Results of a Planned Analysis of the Effects of Genetic Background on Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH). A1012–A1012. 1 indexed citations
3.
Humbert, Marc, Vallerie V. McLaughlin, Mardi Gomberg‐Maitland, et al.. (2022). PULSAR Open-Label Extension: Long-Term Efficacy and Safety of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH). A2150–A2150. 1 indexed citations
4.
Gillies, Hunter, Ralph W. Niven, Benjamin T. Dake, et al.. (2022). AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose study. ERJ Open Research. 9(2). 433–2022. 21 indexed citations
5.
6.
7.
Radosevich, John, et al.. (2020). Comparison of shock reversal with high or low dose hydrocortisone in intensive care unit patients with septic shock: A retrospective cohort study. Journal of Critical Care. 62. 111–116. 4 indexed citations
8.
9.
Feldman, Jeremy P., et al.. (2020). INSPIRE: Final Results from a Phase 3, Open-Label, Pivotal Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension. The Journal of Heart and Lung Transplantation. 39(4). S17–S18. 2 indexed citations
10.
11.
Feldman, Jeremy P., et al.. (2017). Blue after splenectomy. Respiratory Medicine Case Reports. 21. 164–166.
12.
Chakinala, Murali M., Jeremy P. Feldman, Franz Rischard, et al.. (2016). Transition from parenteral to oral treprostinil in pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation. 36(2). 193–201. 47 indexed citations
13.
Bourge, Robert C., Aaron B. Waxman, Mardi Gomberg‐Maitland, et al.. (2016). Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System. CHEST Journal. 150(1). 27–34. 39 indexed citations
14.
Buckley, Mitchell S., et al.. (2011). Pharmacokinetic evaluation of ambrisentan. Expert Opinion on Drug Metabolism & Toxicology. 7(3). 371–380. 15 indexed citations
15.
Feldman, Jeremy P., et al.. (2010). Does 16-Week Response Predict Long-term Success? Results From a 52-Week Analysis of Patients Receiving 40 mg Once-Daily Tadalafil. CHEST Journal. 138(4). 364A–364A. 1 indexed citations
16.
Buckley, Mitchell S. & Jeremy P. Feldman. (2010). Inhaled Epoprostenol for the Treatment of Pulmonary Arterial Hypertension in Critically Ill Adults. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(7). 728–740. 31 indexed citations
17.
18.
Buckley, Mitchell S. & Jeremy P. Feldman. (2007). Nebulized Milrinone Use in a Pulmonary Hypertensive Crisis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(12). 1763–1766. 23 indexed citations
19.
Feldman, Jeremy P., Murali M. Chakinala, Fernando Torres, et al.. (2007). TREPROSTINIL SODIUM IMPROVES EXERCISE CAPACITY WHEN ADDED TO EXISTING ORAL PULMONARY ARTERIAL HYPERTENSION THERAPY. CHEST Journal. 132(4). 474B–474B. 2 indexed citations
20.
Feldman, Jeremy P., Jeffrey A. Feinstein, John J. Lamberti, & Stanton B. Perry. (2005). Angiojet catheter‐based thrombectomy in a neonate with postoperative pulmonary embolism. Catheterization and Cardiovascular Interventions. 66(3). 442–445. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Pielsticker Breakdown of academic impact, for papers by Ségolène Turquier Breakdown of academic impact, for papers by Efrén Santos Breakdown of academic impact, for papers by Athiththan Yogeswaran Breakdown of academic impact, for papers by Maurizio Pin Breakdown of academic impact, for papers by Emir Karaçağlar Breakdown of academic impact, for papers by Katarzyna Małaczyńska-Rajpold Breakdown of academic impact, for papers by Janette T. Reyes Breakdown of academic impact, for papers by Rachel Crackett Breakdown of academic impact, for papers by Willemijn M. H. Zijlstra
Rankless by CCL
2026